Doctor Adam Goldman
Chaim Sheba Medical Center, Tel Hashomer (Israel)
PCSK9 inhibitors associated hyperglycemic disorders: a real world, pharmacovigilance study
Event: ESC Congress 2021 - The Digital Experience
Topic: Lipid-Lowering Agents
Session: Congress committee e-posters choice in pharmacology and pharmacotherapy
ESC 365 is supported by
